Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0470
-0.0010 (-2.08%)
Oct 1, 2026, 3:50 PM AEST
Arovella Therapeutics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -6.92 | -7.51 | -8.75 | -10.18 | -8.62 |
Depreciation & Amortization | 0.12 | 0.11 | 0.04 | 0.14 | 0.2 |
Other Amortization | - | - | - | 0.69 | 0.36 |
Asset Writedown & Restructuring Costs | - | - | - | 1.56 | 0.85 |
Stock-Based Compensation | 0.48 | 0.84 | 1.05 | 0.87 | 0.58 |
Other Operating Activities | 0.09 | 0.01 | 0.1 | 0.01 | 0.44 |
Change in Accounts Receivable | - | - | -0.01 | 0.03 | 0.5 |
Change in Accounts Payable | -0.64 | -0.6 | 0.58 | 0.22 | -0.27 |
Change in Other Net Operating Assets | -0.04 | 0.22 | 0.07 | 0.26 | -0.3 |
Operating Cash Flow | -6.91 | -6.93 | -6.91 | -6.4 | -6.27 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.04 | -0.41 | -0.13 | -0 | -0.04 |
Sale of Property, Plant & Equipment | - | - | - | 0.1 | - |
Sale (Purchase) of Intangibles | - | - | - | - | -0.53 |
Other Investing Activities | -0 | -0.02 | -0.05 | - | - |
Investing Cash Flow | -0.04 | -0.43 | -0.18 | 0.1 | -0.57 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Repaid | - | - | - | -0.07 | -0.07 |
Lease Payments | - | - | - | -0.07 | -0.07 |
Total Debt Repaid | - | - | - | -0.07 | -0.07 |
Net Debt Issued (Repaid) | - | - | - | -0.07 | -0.07 |
Issuance of Common Stock | 0.51 | 16.81 | 14.61 | 5.48 | 6.26 |
Other Financing Activities | -0.02 | -1.29 | - | - | - |
Financing Cash Flow | 0.49 | 15.52 | 14.61 | 5.41 | 6.19 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0.07 | 0 | 0.02 | - | - |
Net Cash Flow | -6.52 | 8.16 | 7.54 | -0.9 | -0.65 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -6.95 | -7.34 | -7.04 | -6.4 | -6.3 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -198.55% | -213.45% | -360.80% | -439.99% | -2130.85% |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Levered Free Cash Flow | -4.93 | -4.8 | -4.42 | -3.19 | -4.37 |
Unlevered Free Cash Flow | -4.93 | -4.8 | -4.42 | -3.18 | -4.25 |
Free Cash Flow After Leases | -6.95 | -7.34 | -7.04 | -6.47 | -6.37 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | - | - | - | 0.02 | 0.18 |
Cash Income Tax Paid | -3.5 | -3.3 | -1.94 | -1.05 | -0.52 |
Change in Working Capital | -0.68 | -0.38 | 0.64 | 0.51 | -0.07 |